# A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis

> **NCT00727740** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 117 (actual)

## Conditions studied

- Pancreatitis

## Interventions

- **DRUG:** Indomethacin
- **DRUG:** Placebo suspension

## Key facts

- **NCT ID:** NCT00727740
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2011-08
- **Final completion:** 2012-08
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727740, "A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00727740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*